SignatureFD’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.1K | Sell |
126
-10
| -7% | -$3.03K | ﹤0.01% | 1727 |
|
2025
Q1 | $45K | Buy |
136
+3
| +2% | +$994 | ﹤0.01% | 1622 |
|
2024
Q4 | $41K | Sell |
133
-6
| -4% | -$1.85K | ﹤0.01% | 1682 |
|
2024
Q3 | $29.5K | Sell |
139
-6
| -4% | -$1.27K | ﹤0.01% | 1849 |
|
2024
Q2 | $40.6K | Buy |
145
+39
| +37% | +$10.9K | ﹤0.01% | 1613 |
|
2024
Q1 | $28.3K | Buy |
106
+4
| +4% | +$1.07K | ﹤0.01% | 1821 |
|
2023
Q4 | $23.6K | Buy |
102
+10
| +11% | +$2.31K | ﹤0.01% | 1837 |
|
2023
Q3 | $13.4K | Buy |
92
+53
| +136% | +$7.74K | ﹤0.01% | 2045 |
|
2023
Q2 | $9.01K | Hold |
39
| – | – | ﹤0.01% | 2276 |
|
2023
Q1 | $9.45K | Hold |
39
| – | – | ﹤0.01% | 2238 |
|
2022
Q4 | $11.3K | Buy |
+39
| New | +$11.3K | ﹤0.01% | 2087 |
|
2022
Q1 | – | Sell |
-54
| Closed | -$5K | – | 3245 |
|
2021
Q4 | $5K | Buy |
54
+50
| +1,250% | +$4.63K | ﹤0.01% | 2397 |
|
2021
Q3 | $0 | Sell |
4
-33
| -89% | – | ﹤0.01% | 3137 |
|
2021
Q2 | $4K | Sell |
37
-8
| -18% | -$865 | ﹤0.01% | 2352 |
|
2021
Q1 | $5K | Buy |
+45
| New | +$5K | ﹤0.01% | 2139 |
|
2020
Q3 | – | Sell |
-7
| Closed | -$1K | – | 2675 |
|
2020
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 2323 |
|